171 related articles for article (PubMed ID: 11953462)
1. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.
Gillespie GM; Kaul R; Dong T; Yang HB; Rostron T; Bwayo JJ; Kiama P; Peto T; Plummer FA; McMichael AJ; Rowland-Jones SL
AIDS; 2002 May; 16(7):961-72. PubMed ID: 11953462
[TBL] [Abstract][Full Text] [Related]
2. Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians.
Currier JR; Harris ME; Cox JH; McCutchan FE; Birx DL; Maayan S; Ferrari G
AIDS Res Hum Retroviruses; 2005 Mar; 21(3):239-45. PubMed ID: 15795531
[TBL] [Abstract][Full Text] [Related]
3. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
Goulder PJ; Brander C; Annamalai K; Mngqundaniso N; Govender U; Tang Y; He S; Hartman KE; O'Callaghan CA; Ogg GS; Altfeld MA; Rosenberg ES; Cao H; Kalams SA; Hammond M; Bunce M; Pelton SI; Burchett SA; McIntosh K; Coovadia HM; Walker BD
J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876
[TBL] [Abstract][Full Text] [Related]
4. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
[TBL] [Abstract][Full Text] [Related]
5. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
[TBL] [Abstract][Full Text] [Related]
8. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
Goulder PJ; Bunce M; Krausa P; McIntyre K; Crowley S; Morgan B; Edwards A; Giangrande P; Phillips RE; McMichael AJ
AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1691-8. PubMed ID: 8959245
[TBL] [Abstract][Full Text] [Related]
9. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
[TBL] [Abstract][Full Text] [Related]
10. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
[TBL] [Abstract][Full Text] [Related]
11. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants.
Simons BC; Vancompernolle SE; Smith RM; Wei J; Barnett L; Lorey SL; Meyer-Olson D; Kalams SA
J Immunol; 2008 Oct; 181(7):5137-46. PubMed ID: 18802118
[TBL] [Abstract][Full Text] [Related]
12. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
[TBL] [Abstract][Full Text] [Related]
13. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
[TBL] [Abstract][Full Text] [Related]
14. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
[TBL] [Abstract][Full Text] [Related]
15. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y
J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
Kalams SA; Johnson RP; Dynan MJ; Hartman KE; Harrer T; Harrer E; Trocha AK; Blattner WA; Buchbinder SP; Walker BD
J Exp Med; 1996 Apr; 183(4):1669-79. PubMed ID: 8666925
[TBL] [Abstract][Full Text] [Related]
17. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
[TBL] [Abstract][Full Text] [Related]
18. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
[TBL] [Abstract][Full Text] [Related]
19. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.
Ladell K; Hashimoto M; Iglesias MC; Wilmann PG; McLaren JE; Gras S; Chikata T; Kuse N; Fastenackels S; Gostick E; Bridgeman JS; Venturi V; Arkoub ZA; Agut H; van Bockel DJ; Almeida JR; Douek DC; Meyer L; Venet A; Takiguchi M; Rossjohn J; Price DA; Appay V
Immunity; 2013 Mar; 38(3):425-36. PubMed ID: 23521884
[TBL] [Abstract][Full Text] [Related]
20. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
